1. Park TS, Lee ST, Song J, Lee KA, Kim J, Kim SJ, et al. A tandem triplication, trp(1)(q21q32), in a patient with follicular lymphoma: a case study and review of the literature. Cancer Genet Cytogenet. 2009; 189:127–131.
Article
2. Park TS, Lee SG, Cheong JW, Song J, Lee KA, Kim J, et al. Two case reports of 1q triplication in myeloproliferative neoplasms. Cancer Genet Cytogenet. 2009; 191:111–112.
Article
3. Ha JS, Choi MS. 1q triplication as sole cytogenetic abnormality in myelodysplastic syndrome. Leuk Lymphoma. 2011; 52:1387–1389.
Article
4. Swerdlow SH, Campo E, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC;2017. p. 44–50.
5. Wassie E, Finke C, Gangat N, Lasho TL, Pardanani A, Hanson CA, et al. A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients. Br J Haematol. 2015; 169:71–76.
Article
6. Reilly JT. Cytogenetic and molecular genetic aspects of idiopathic myelofibrosis. Acta Haematol. 2002; 108:113–119.
Article
7. Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li CY, Deward GW. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol. 2001; 113:763–771.
Article